Patent Number: 6,617,321

Title: 2-methyl-thieno-benzodiazepine formulation

Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation or olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.

Inventors: Allen; Douglas J. (Indianapolis, IN), Dekemper; Kurt D. (Franklin, IN), Ferguson; Thomas H. (Greenfield, IN), Garvin; Stuart J. (Plainfield, IN), Murray; Linda C. (Noblesville, IN), Brooks; Norman D. (Greenfield, IN), Bunnell; Charles A. (Lafayette, IN), Mascarenhas; Snehlata S. (Indianapolis, IN), Shinkle; Sharon L. (Indianapolis, IN), Hendriksen; Barry A. (Guildford, GB), Tupper; David E. (Reading, GB), Sanchez-Felix; Manuel V. (Grayshott, GB)

Assignee: Eli Lilly and Company

International Classification: A61K 9/16 (20060101); A61K 47/00 (20060101); A61K 31/551 (20060101); C07D 495/00 (20060101); C07D 495/04 (20060101); A61K 47/36 (20060101); A61K 47/22 (20060101); A61K 47/38 (20060101); A61K 47/28 (20060101); A61K 47/26 (20060101); A61K 47/24 (20060101); A61K 47/14 (20060101); A61K 47/32 (20060101); A61K 47/10 (20060101); A61K 031/55 ()

Expiration Date: 09/09/2020